Cargando…

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma

BACKGROUND: The prognostic effect of tumour budding was retrospectively analysed in a cohort of 173 patients with resected pancreatic ductal adenocarcinomas (PDACs) of the prospective clinical multicentre CONKO-001 trial. METHODS: Haematoxylin and eosin (H&E)-stained whole tissue slides were eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohneis, Philipp, Sinn, Marianne, Klein, Fritz, Bischoff, Sven, Striefler, Jana K., Wislocka, Lilianna, Sinn, Bruno V., Pelzer, Uwe, Oettle, Helmut, Riess, Hanno, Denkert, Carsten, Bläker, Hendrik, Jühling, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988658/ https://www.ncbi.nlm.nih.gov/pubmed/29755112 http://dx.doi.org/10.1038/s41416-018-0093-y

Ejemplares similares

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
por: Striefler, Jana Käthe, et al.
Publicado: (2021)

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
por: Sinn, M, et al.
Publicado: (2014)

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation
por: Striefler, Jana K., et al.
Publicado: (2022)

Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
por: Pelzer, Uwe, et al.
Publicado: (2013)

Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study
por: Pelzer, Uwe, et al.
Publicado: (2010)

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial
por: Pelzer, Uwe, et al.
Publicado: (2014)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy
por: Sinn, M., et al.
Publicado: (2014)

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
por: Hoyer, K., et al.
Publicado: (2021)

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
por: Riess, Hanno, et al.
Publicado: (2008)

Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
por: Cheung, Phyllis F., et al.
Publicado: (2022)

Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum
por: Gül-Klein, Safak, et al.
Publicado: (2018)

Blood group determinates incidence for pancreatic cancer in Germany
por: Pelzer, U., et al.
Publicado: (2013)

Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Heitz, Florian, et al.
Publicado: (2019)

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161)
por: Sinn, Marianne, et al.
Publicado: (2013)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
por: Felsenstein, Matthäus, et al.
Publicado: (2022)

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
por: Budczies, Jan, et al.
Publicado: (2012)

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Ihlow, Jana, et al.
Publicado: (2022)

Elevated reticulocyte count – a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report
por: Serke, S, et al.
Publicado: (1999)

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
por: Stenzinger, Albrecht, et al.
Publicado: (2013)

Complexity and Resource Bound Analysis of Imperative Programs Using Difference Constraints
por: Sinn, Moritz, et al.
Publicado: (2017)

Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
por: Felsenstein, Matthäus, et al.
Publicado: (2023)

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences
por: Kriegsmann, Mark, et al.
Publicado: (2014)

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma
por: Nitschke, Christine, et al.
Publicado: (2022)

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
por: Nitschke, Christine, et al.
Publicado: (2022)

Retention time prediction using neural networks increases identifications in crosslinking mass spectrometry
por: Giese, Sven H., et al.
Publicado: (2021)

Mechanisims of asthma and allergic disease – 1074. Prebiotics in infants for prevention of allergic disease and hypersensitiivity
por: Sinn, John
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1075. Probiotics in infants for prevention of allergic disease and food hypersensitivity
por: Sinn, John
Publicado: (2013)

Denarcotized Opium in Fever
por: Sinn, W. S.
Publicado: (1855)

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2016)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

Hosting and managing large sets of virtual microscopy slides on the internet for E-learning and for reference
por: Sinn, Hans-Peter
Publicado: (2013)

Extreme hypofractionation in radiation therapy for patients with early breast cancer: what is the optimal technique?
por: Chin, Yaw Sinn
Publicado: (2022)

Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study
por: Karamitopoulou, Eva, et al.
Publicado: (2020)

Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2016)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy
por: Wimberger, Pauline, et al.
Publicado: (2023)

Saccadic facilitation by modulation of microsaccades in natural backgrounds
por: Sinn, Petra, et al.
Publicado: (2011)

Treffen der AG Gastroenteropathologie am 10. Juni 2021: 105. jährliche Tagung der Deutschen Pathologischen Gesellschaft, Onlinekonferenz
por: Bläker, Hendrik
Publicado: (2021)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
por: Leichsenring, Jonas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tc2mesaol4gss0bjn9lg97olq3